nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—Hepatic steatosis—Octreotide—thymus cancer	0.102	0.102	CcSEcCtD
Etravirine—Osteonecrosis—Octreotide—thymus cancer	0.0829	0.0829	CcSEcCtD
Etravirine—Gynaecomastia—Octreotide—thymus cancer	0.0276	0.0276	CcSEcCtD
Etravirine—Sleep disorder—Octreotide—thymus cancer	0.0259	0.0259	CcSEcCtD
Etravirine—Diabetes mellitus—Octreotide—thymus cancer	0.0258	0.0258	CcSEcCtD
Etravirine—Amnesia—Octreotide—thymus cancer	0.0239	0.0239	CcSEcCtD
Etravirine—Dry skin—Octreotide—thymus cancer	0.0205	0.0205	CcSEcCtD
Etravirine—Gastritis—Octreotide—thymus cancer	0.0198	0.0198	CcSEcCtD
Etravirine—Abdominal distension—Octreotide—thymus cancer	0.0195	0.0195	CcSEcCtD
Etravirine—Bronchospasm—Octreotide—thymus cancer	0.0191	0.0191	CcSEcCtD
Etravirine—Pancreatitis—Octreotide—thymus cancer	0.019	0.019	CcSEcCtD
Etravirine—Hyperglycaemia—Octreotide—thymus cancer	0.0175	0.0175	CcSEcCtD
Etravirine—Neuropathy peripheral—Octreotide—thymus cancer	0.0169	0.0169	CcSEcCtD
Etravirine—Conjunctivitis—Octreotide—thymus cancer	0.0168	0.0168	CcSEcCtD
Etravirine—Hepatobiliary disease—Octreotide—thymus cancer	0.0163	0.0163	CcSEcCtD
Etravirine—Hepatitis—Octreotide—thymus cancer	0.0155	0.0155	CcSEcCtD
Etravirine—Hypoaesthesia—Octreotide—thymus cancer	0.0154	0.0154	CcSEcCtD
Etravirine—Cardiac disorder—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Etravirine—Immune system disorder—Octreotide—thymus cancer	0.014	0.014	CcSEcCtD
Etravirine—Mental disorder—Octreotide—thymus cancer	0.0136	0.0136	CcSEcCtD
Etravirine—Malnutrition—Octreotide—thymus cancer	0.0135	0.0135	CcSEcCtD
Etravirine—Flatulence—Octreotide—thymus cancer	0.0133	0.0133	CcSEcCtD
Etravirine—Tension—Octreotide—thymus cancer	0.0132	0.0132	CcSEcCtD
Etravirine—Nervousness—Octreotide—thymus cancer	0.0131	0.0131	CcSEcCtD
Etravirine—Vision blurred—Octreotide—thymus cancer	0.0127	0.0127	CcSEcCtD
Etravirine—Tremor—Octreotide—thymus cancer	0.0126	0.0126	CcSEcCtD
Etravirine—Ill-defined disorder—Octreotide—thymus cancer	0.0125	0.0125	CcSEcCtD
Etravirine—Anaemia—Octreotide—thymus cancer	0.0125	0.0125	CcSEcCtD
Etravirine—Malaise—Octreotide—thymus cancer	0.0122	0.0122	CcSEcCtD
Etravirine—Vertigo—Octreotide—thymus cancer	0.0121	0.0121	CcSEcCtD
Etravirine—Syncope—Octreotide—thymus cancer	0.0121	0.0121	CcSEcCtD
Etravirine—Loss of consciousness—Octreotide—thymus cancer	0.0119	0.0119	CcSEcCtD
Etravirine—Convulsion—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Etravirine—Hypertension—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Etravirine—Anxiety—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Etravirine—Discomfort—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Etravirine—Dry mouth—Octreotide—thymus cancer	0.0112	0.0112	CcSEcCtD
Etravirine—Infection—Octreotide—thymus cancer	0.0109	0.0109	CcSEcCtD
Etravirine—Shock—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Etravirine—Nervous system disorder—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Etravirine—Thrombocytopenia—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Etravirine—Skin disorder—Octreotide—thymus cancer	0.0107	0.0107	CcSEcCtD
Etravirine—Hyperhidrosis—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Etravirine—Anorexia—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Etravirine—Insomnia—Octreotide—thymus cancer	0.00996	0.00996	CcSEcCtD
Etravirine—Paraesthesia—Octreotide—thymus cancer	0.00989	0.00989	CcSEcCtD
Etravirine—Somnolence—Octreotide—thymus cancer	0.00979	0.00979	CcSEcCtD
Etravirine—Decreased appetite—Octreotide—thymus cancer	0.00957	0.00957	CcSEcCtD
Etravirine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00951	0.00951	CcSEcCtD
Etravirine—Fatigue—Octreotide—thymus cancer	0.0095	0.0095	CcSEcCtD
Etravirine—Pain—Octreotide—thymus cancer	0.00942	0.00942	CcSEcCtD
Etravirine—Constipation—Octreotide—thymus cancer	0.00942	0.00942	CcSEcCtD
Etravirine—Feeling abnormal—Octreotide—thymus cancer	0.00908	0.00908	CcSEcCtD
Etravirine—Gastrointestinal pain—Octreotide—thymus cancer	0.00901	0.00901	CcSEcCtD
Etravirine—Abdominal pain—Octreotide—thymus cancer	0.00871	0.00871	CcSEcCtD
Etravirine—Body temperature increased—Octreotide—thymus cancer	0.00871	0.00871	CcSEcCtD
Etravirine—Hypersensitivity—Octreotide—thymus cancer	0.00811	0.00811	CcSEcCtD
Etravirine—Asthenia—Octreotide—thymus cancer	0.0079	0.0079	CcSEcCtD
Etravirine—Diarrhoea—Octreotide—thymus cancer	0.00754	0.00754	CcSEcCtD
Etravirine—Dizziness—Octreotide—thymus cancer	0.00728	0.00728	CcSEcCtD
Etravirine—Vomiting—Octreotide—thymus cancer	0.007	0.007	CcSEcCtD
Etravirine—Rash—Octreotide—thymus cancer	0.00694	0.00694	CcSEcCtD
Etravirine—Dermatitis—Octreotide—thymus cancer	0.00694	0.00694	CcSEcCtD
Etravirine—Headache—Octreotide—thymus cancer	0.0069	0.0069	CcSEcCtD
Etravirine—Nausea—Octreotide—thymus cancer	0.00654	0.00654	CcSEcCtD
